🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New evidence today NEJM that age-related clonal hematopoiesis (CHIP) has a driver role in evolution of solid cancers nejm.org/doi/full/10.10… nejm.org/doi/full/10.10…

The risk of developing blood cancer increases with age. The finding that a molecule from gut bacteria plays a part points to new ways to intervene. go.nature.com/42PWPQN

Saber Excel es oro. Tómate un día y aprende esto. Aquí hay 25 funciones de Excel que debes conocer:

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes ascopubs.org/doi/10.1200/JC…

The molecular landscape of AL amyloidosis onlinelibrary.wiley.com/doi/10.1111/bj… #mmsm

Víctor participa en algo muy especial…. se trata de #ElViajeDeNica y busca mejorar el diagnóstico de enfermedades raras. Él mismo explica maravillosamente su historia y la campaña. Para COMPARTIR Y DONAR: elviajedenica.org/es/nicas/010 GRACIAS 🙏❤️

🔬 Check out our latest work on the evolution of #MDS to #AML In this brief paper, we show how changes in MSC content measured by flow cytometry at diagnosis can help predict #Leukemia Tranformation. onlinelibrary.wiley.com/doi/10.1002/jh…

The loss of Y-chromosome in men affects the immune system's T cells and helps explain higher risk cancer mortality nature.com/articles/d4158…

Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. pubmed.ncbi.nlm.nih.gov/40040251/ #CH #CCUS #R525H

How I treat secondary acute myeloid leukemia ashpublications.org/blood/article-… #leusm #AML

Single-cell multi-omics: a brief review of the principles of single-cell technologies, their historical development and ever-expanding multi-omics tools. haematologica.org/article/view/1…

Although there is a body of evidence linking cancer stem cells to therapy resistance in acute myeloid leukemia, some work has challenged this idea. ow.ly/oYcr50W5eAP #hematopoiesisandstemcells

Just out! New IMS/ IMWG Definition of High Risk Myeloma. Journal of Clinical Oncology #IMWG25 Myeloma Society International Myeloma Foundation Nikhil C. Munshi, MD marivi mateos Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Noopur Raje

Just out: Mayo Clinic mSMART Risk Stratification of Myeloma #EHA25 1/ We recommend and use same high risk cytogenetic definition as the latest IMS/IMWG paper 2/ Primary plasma cell leukemia is high risk myeloma 3/ We define Double-hit high risk myeloma msmart.org/mm-treatment-g…

TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/…

Peripheral blood flow cytometry was initially interpreted to be suggestive of marginal zone lymphoma. ow.ly/KnGl50W8NZr #BloodWork #lymphoidneoplasia

TP53-mutated acute myeloid leukemia and myelodysplastic syndrome are now well established as their own unique diagnostic entity, characterized by an exceptionally poor prognosis and inadequate therapeutic options. ow.ly/XMBu50WagUw #BloodSpotlight #myeloidneoplasia

Just out: Guidelines for testing and reporting cytogenetic results in myeloma Blood Cancer Journal⁩ #OpenAccess Bookmark! Allows you to incorporate latest IMS/IMWG high risk criteria in practice. ⁦Linda B. Baughn⁩ ⁦Rahul Banerjee, MD, FACP⁩ ⁦Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽⁩ nature.com/articles/s4140…

Patients with TP53-mutated AML/MDS represent a unique and heterogeneous high-risk group that should not be treated as 1 single entity. ow.ly/tEXM50W7tLk #myeloidneoplasia #transplantation #clinicaltrialsandobservations

How I treat Wiskott-Aldrich syndrome ow.ly/8yua50WmijX #HowITreat #genetherapy #immunobiologyandimmunotherapy #plateletsandthrombopoiesis #transplantation